Thrombolysis in Pulmonary Embolism
- 11 December 2001
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (24), 2876-2878
- https://doi.org/10.1161/circ.104.24.2876
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Long-term benefit of thrombolytic therapy in patients with pulmonary embolismVascular Medicine, 2000
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary EmbolismNew England Journal of Medicine, 1997
- Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusionThe Lancet, 1993
- PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2Journal of the American College of Cardiology, 1992
- The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic TreatmentNew England Journal of Medicine, 1992
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionThe Lancet, 1992
- A Randomized Trial of a Single Bolus Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Acute Pulmonary EmbolismChest, 1990
- Fibrinolytic Effects of Urokinase and Heparin in Acute Pulmonary Embolism: A Randomized Clinical TrialRespiration, 1988
- A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary EmbolismActa Medica Scandinavica, 1978
- Comparison by Controlled Clinical Trial of Streptokinase and Heparin in Treatment of Life-threatening Pulmonary EmbolismBMJ, 1974